AVITA Medical Announces Achievement of Co-Primary Endpoints in Updated Analysis of Pivotal Trial of RECELL® System for Soft Tissue Repair | AVITA Medical
FDA Breakthrough Device Designations for VITILIGO & Soft Tissue for the RECELL® System, page-39
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.03 |
Change
-0.050(1.62%) |
Mkt cap ! $213.3M | |||
| Open | High | Low | Value | Volume |
| $3.08 | $3.08 | $3.00 | $295.3K | 97.80K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1819 | $3.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.05 | 71 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| AVH (ASX) Chart |